Name and surname:
|
Mgr. Lucia Kučerová, DrSc.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Independent researcher | Cancer Research Institute SAS | 1999-2015 |
Principal investigator - senior researcher | Cancer Research Institute, Biomedical Research Center SAS | 2016-present |
Research scientist | Translational Research Unit, 2nd Oncology Clinic, Medical Faculty, Comenius University | 2022-present |
Senior research manager | Glycostem BV, Oss, the Netherlands | 2019-2023 |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
State exam English language C1, 12.1.1994 | Faculty of Natural Sciences, Comenius University | 1994 |
V.2.a - Name of the study programme | V.2.b - Degree | V.2.c - Field of study |
---|---|---|
Oncology | III. | General Medicine |
Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy, Authors: Kucerova, Lucia; Altanerova, Veronika; Matuskova, Miroslava; ... Altaner, Cestmir; Published:Jul 2007 in Cancer Research, DOI: 10.1158/0008-5472.CAN-06-4024
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. Mikula, M; Schreiber, M; Husak, Z, Kucerova, L; Ruth, J ; Wieser, R ; Zatloukal, K ; Beug, H ; Wagner, EF; Baccarini, M. )Published:Apr 2001 in The EMBO Journal, DOI: 10.1093/EMBOJ/20.8.1952
Tumor cell behaviour modulation by mesenchymal stromal cells. Kucerova, Lucia; Matuskova, Miroslava; Hlubinova, Kristina; ... Altaner, Cestmir; Published:May 2010 in Molecular Cancer, DOI: 10.1186/1476-4598-9-129
Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. Kucerova, Lucia; Matuskova, Miroslava; Pastorakova, Andrea; ... Altaner, Cestmir; Published:Oct 2008 in Journal of Gene Medicine, DOI: 10.1002/JGM.1239
Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells. Kucerova, Lucia; Skolekova, Svetlana; Matuskova, Miroslava; ... Kozovska, Zuzana; Published: 2013 in BMC Cancer
Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer. Plava, Jana; Burikova, Monika; Cihova, Marina; ... Kucerova, Lucia, Miklikova, Svetlana; Published: Sep 2021 in Journal of Experimental & Clinical Cancer Research, DOI: 10.1186/S13046-021-02087-2
Genetic Engineering of Natural Killer Cells for Enhanced Antitumor Function, Mantesso, Simone; Geerts, Dirk; Spanholtz, Jan; Kucerova, Lucia, Published: Dec 2020 in Frontiers in Immunology, DOI: 10.3389/FIMMU.2020.607131
Permanent Pro-Tumorigenic Shift in Adipose Tissue-Derived Mesenchymal Stromal Cells Induced by Breast Malignancy. Plava, Jana; Cihova, Marina; Burikova, Monika; ... Kucerova, Lucia, Miklikova, Svetlana; Published: Feb 2020 in Cells, DOI: 10.3390/CELLS9020480
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer. Plava, Jana; Cihova, Marina; Burikova, Monika; ... Kucerova, Lucia, Miklikova, Svetlana; Published: Mar 2019 in Molecular Cancer, DOI: 10.1186/S12943-019-0960-Z
SCHMIDTOVÁ, Silvia - UDVORKOVÁ, Natália - ČIERNA, Zuzana - HORAK, Samuel - KAĽAVSKÁ, Katarína - CHOVANEC, Michal - ROJIKOVÁ, Lucia - VULEVOVÁ, Miriam - KUČEROVÁ, Lucia* - MEGO, Michal*. Effect of the PARP inhibitor veliparib on germ cell tumor cell lines. In Oncology Letters, 2022, vol.24, no. 5, art. no. 392. (2021: 3.111 - IF, Q3 - JCR, 0.639 - SJR, Q3 - SJR). Typ: ADMA
The work was cited more then 2873 times, Hirsch index H=26.Publication: Kucerova L et al., Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010 May 28;9:129. doi: 10.1186/1476-4598-9-129. Cited in: Di Franco S et al., Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery. Nat Commun. 2021 Aug 18;12(1):5006. doi: 10.1038/s41467-021-25333-9.
Publication: Kucerova L et al., Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer. 2010 May 28;9:129. doi: 10.1186/1476-4598-9-129. Cited in: Ridge SM et al., Mesenchymal stem cells: key players in cancer progression. Mol Cancer. 2017 Feb 1;16(1):31. doi: 10.1186/s12943-017-0597-8
Publication: Kucerova L et al., Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007 Jul 1;67(13):6304-13. doi: 10.1158/0008-5472. Cited in: Yin Z et al., Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy. Mol Cancer. 2018 Dec 28;17(1):178. doi: 10.1186/s12943-018-0926-6.
Publication: Kucerova L et al., Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res. 2007 Jul 1;67(13):6304-13. doi: 10.1158/0008-5472. Cited in: Srifa W et al., Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice. Nat Commun. 2020 May 18;11(1):2470. doi: 10.1038/s41467-020-16065-3
Publication: Kucerova & Skolekova, Tumor microenvironment and the role of mesenchymal stromal cells. Neoplasma. 2013;60(1):1-10. doi: 10.4149/neo_2013_001. Cited in: Daunys S et al., 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles. Adv Exp Med Biol. 2021;1295:243-270. doi: 10.1007/978-3-030-58174-9_11.
7th Joint Transnational Call for Proposals of the EuroNanomed Initiative in EuroNanoMed II Projekt INNOCENT, 2017-2020, Consortium coordinator/coinvestigator since 2018
APVV-16-0178 Mechanizmus tolerancie indukovanej mezenchýmovými stromálnymi bunkami voči protinádorovej liečbe a cielená terapeutická intervencia v nádorových bunkách karcinómu prsníka, (2016-2021) Principal investigator
APVV-16-0010 Identifikácia a validácia signálnych dráh asociovaných s cirkulujúcimi nádorovými bunkami pri karcinóme prsníka, (2016-21) Zodpovedný riešiteľ: prof. MUDr. Michal Mego, DrSc., Principal investigator CRI BMC SAS
APVV-15-0697 Úloha CA IX v adaptácii na nádorové mikroprostredie a v rezistencii na protinádorovú terapiu: molekulárne mechanizmy a klinické implikácie, (2015-2020) Co- investigator CRI BMC SAS
APVV-21-0158 Identification of new treatment options in refractory testicular germ cell tumors, (2021-2025) Co- investigator
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
Member of the dosctoral study program, oncoolgy 7.1.15 | Comenius University in Bratislava, Faculty of Medicine | 2016-present |
Member of the Board for the PhD theses defense | Comenius University in Bratislava, Faculty of Medicine | 2016-present |
Member VEGA, Meber of the Comission VEGA nr. 9 for medical and pharmaceutical sciences | Slovak Academy of Sciences | 2014-2018 |
Scientific board member | Cancer Resrarch Institute SAS | 2011-2015 |